Cometriq (cabozantinib)

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) May 2016 WARNINGS AND PRECAUTIONS Embryo-Fetal Toxicity Based on data from animal studies and its mechanism of action, COMETRIQ...
Source: Drugs.com - Labeling Changes - Category: Drugs & Pharmacology Source Type: alerts